Clinical Trial Update: An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating a test product in combination with a marketed prescription product for hyperpigmentation is enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperpigmentation

Drugs mentioned

• Marketed Prescription Product
• Test Product

Snippet

Sponsor: Good Molecules, LLC | Conditions: Hyperpigmentation | Phase 3 | Status: ENROLLING_BY_INVITATION